Analysts have downgraded Trent, citing weak consumption and competition, while Morgan Stanley maintains an overweight rating on Nykaa, impressed by its beauty and fashion business growth. Goldman Sachs holds a neutral stance on Divis Laboratories, noting strong Q2FY26 performance driven by custom synthesis.